BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yoshikawa S, Zen Y, Fujii T, Sato Y, Ohta T, Aoyagi Y, Nakanuma Y. Characterization of CD133+ parenchymal cells in the liver: Histology and culture. World J Gastroenterol 2009; 15(39): 4896-4906 [PMID: 19842219 DOI: 10.3748/wjg.15.4896]
URL: https://www.wjgnet.com/1007-9327/full/v15/i39/4896.htm
Number Citing Articles
1
T Wang, H S Hu, Y X Feng, J Shi, N Li, W X Guo, J Xue, D Xie, S R Liu, M C Wu, S Q Cheng. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinomaBritish Journal of Cancer 2010; 102(11): 1618 doi: 10.1038/sj.bjc.6605689
2
Hiroko Ikeda, Kenichi Harada, Yasunori Sato, Motoko Sasaki, Norihide Yoneda, Seiko Kitamura, Yoshiko Sudo, Akishi Ooi, Yasuni Nakanuma. Clinicopathologic Significance of Combined Hepatocellular-Cholangiocarcinoma With Stem Cell Subtype Components With Reference to the Expression of Putative Stem Cell MarkersAmerican Journal of Clinical Pathology 2013; 140(3): 329 doi: 10.1309/AJCP66AVBANVNTQJ
3
Maurizio Romano, Francesco De Francesco, Giuseppe Pirozzi, Enrico Gringeri, Riccardo Boetto, Marina Di Domenico, Barbara Zavan, Giuseppe A. Ferraro, Umberto Cillo. Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinomaOncoscience 2015; 2(5): 443 doi: 10.18632/oncoscience.163
4
Yu-Chin Liu, Chau-Ting Yeh, Kwang-Huei Lin. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic StrategiesCells 2020; 9(6): 1331 doi: 10.3390/cells9061331
5
Sepideh Alavi Moghaddam, Faezeh Faghihi, Nasim Hayati Roodbari. Differentiation potential of human CD133 and CD34 positive hematopoietic stem cells into motor neuron- like cells; an in vitro studyMEDICAL SCIENCES JOURNAL 2018; 28(2): 92 doi: 10.29252/iau.28.2.92
6
Junfang Ji, Xin Wei Wang. Clinical Implications of Cancer Stem Cell Biology in Hepatocellular CarcinomaSeminars in Oncology 2012; 39(4): 461 doi: 10.1053/j.seminoncol.2012.05.011
7
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic ImplicationsInternational Journal of Molecular Sciences 2019; 20(17): 4154 doi: 10.3390/ijms20174154
8
George S. Wilson, Zenan Hu, Wei Duan, Aiping Tian, Xin M. Wang, Duncan McLeod, Vincent Lam, Jacob George, Liang Qiao. Efficacy of Using Cancer Stem Cell Markers in Isolating and Characterizing Liver Cancer Stem CellsStem Cells and Development 2013; 22(19): 2655 doi: 10.1089/scd.2012.0703
9
Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, George G. Chen. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategiesTherapeutic Advances in Medical Oncology 2018; 10: 175883591881628 doi: 10.1177/1758835918816287
10
Guangqiu Li, Chao Liu, Jian Yuan, Xiaoqin Xiao, Na Tang, Junmei Hao, Hongwei Wang, Xiuwu Bian, Yongjian Deng, Yanqing Ding. CD133+ single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potentialClinical & Experimental Metastasis 2010; 27(7): 517 doi: 10.1007/s10585-010-9341-0
11
Fei Jiang, Juan Mu, Xingxing Wang, Xianqing Ye, Lu Si, Shilong Ning, Zhong Li, Yuan Li, Lian-Yue Yang. The Repressive Effect of miR-148a on TGF beta-SMADs Signal Pathway Is Involved in the Glabridin-Induced Inhibition of the Cancer Stem Cells-Like Properties in Hepatocellular Carcinoma CellsPLoS ONE 2014; 9(5): e96698 doi: 10.1371/journal.pone.0096698
12
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 3 doi: 10.1007/978-3-319-26956-6_1
13
Gongcai Qiu, Donglai Ma, Fujun Li, Dongsheng Sun, Zhaolin Zeng. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinomaInternational Journal of Oncology 2019;  doi: 10.3892/ijo.2019.4798
14
Izuru Ohtsubo, Tetsuo Ajiki, Yuichi Hori, Sae Murakami, Kazuya Shimizu, Tomoo Itoh, Michio Shimizu, Takumi Fukumoto, Yonson Ku. Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomasHepatology Research 2012; 42(6): 574 doi: 10.1111/j.1872-034X.2011.00954.x
15
Li-Li Liu, Da Fu, Yushui Ma, Xi-Zhong Shen. The Power and the Promise of Liver Cancer Stem Cell MarkersStem Cells and Development 2011; 20(12): 2023 doi: 10.1089/scd.2011.0012
16
Hee Ju, Yumi Shim, Parthasarathy Arumugam, Joon Myong Song. Crosstalk-eliminated quantitative determination of aflatoxin B1-induced hepatocellular cancer stem cells based on concurrent monitoring of CD133, CD44, and aldehyde dehydrogenase1Toxicology Letters 2016; 243: 31 doi: 10.1016/j.toxlet.2015.12.006
17
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_1-1
18
Toshio Kokuryo, Yukihiro Yokoyama, Masato Nagino. Recent advances in cancer stem cell research for cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences 2012; 19(6): 606 doi: 10.1007/s00534-012-0542-6
19
Kuo-Shyang Jeng, Ssu-Jung Lu, Chih-Hsuan Wang, Chiung-Fang Chang. Liver Fibrosis and Inflammation under the Control of ERK2International Journal of Molecular Sciences 2020; 21(11): 3796 doi: 10.3390/ijms21113796
20
L Florianova, M Orain, B Têtu, CJ Doillon. Histological study of stem-like cells in human colon adenocarcinoma at different stages of the diseaseBiotechnic & Histochemistry 2013; 88(5): 222 doi: 10.3109/10520295.2012.758310
21
Lu Liu, Jürgen Borlak. Advances in Liver Cancer Stem Cell Isolation and their CharacterizationStem Cell Reviews and Reports 2021; 17(4): 1215 doi: 10.1007/s12015-020-10114-6
22
Maria Assunta Zocco, Anna Chiara Piscaglia, Felice Giuliante, Vincenzo Arena, Marialuisa Novi, Emanuele Rinninella, Annalisa Tortora, Carlo Rumi, Gennaro Nuzzo, Fabio Maria Vecchio, Giuseppe Bombardieri, Antonio Gasbarrini. CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying diseaseDigestive and Liver Disease 2011; 43(2): 147 doi: 10.1016/j.dld.2010.06.008